Pexidartinib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pexidartinib. Educational only — not medical advice.
Labeled uses
TURALIO is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.
Source: FDA labeling via NIH DailyMed (set 7b0ec4bf…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.